Wockhardt Balance Sheet Health
Financial Health criteria checks 6/6
Wockhardt has a total shareholder equity of ₹48.8B and total debt of ₹23.2B, which brings its debt-to-equity ratio to 47.6%. Its total assets and total liabilities are ₹85.3B and ₹36.6B respectively. Wockhardt's EBIT is ₹2.4B making its interest coverage ratio 1.3. It has cash and short-term investments of ₹9.8B.
Key information
47.64%
Debt to equity ratio
₹23.23b
Debt
| Interest coverage ratio | 1.3x |
| Cash | ₹9.78b |
| Equity | ₹48.76b |
| Total liabilities | ₹36.57b |
| Total assets | ₹85.33b |
Recent financial health updates
Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Dec 07
Does Wockhardt (NSE:WOCKPHARMA) Have A Healthy Balance Sheet?
Jun 02Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jul 27Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Recent updates
Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Dec 07Wockhardt Limited's (NSE:WOCKPHARMA) Price Is Out Of Tune With Revenues
Nov 10Here's Why Wockhardt Limited's (NSE:WOCKPHARMA) CEO May Deserve A Raise
Aug 02Wockhardt Limited's (NSE:WOCKPHARMA) 26% Price Boost Is Out Of Tune With Revenues
Jun 11Does Wockhardt (NSE:WOCKPHARMA) Have A Healthy Balance Sheet?
Jun 02There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 25% Price Jump
Apr 02What Wockhardt Limited's (NSE:WOCKPHARMA) 31% Share Price Gain Is Not Telling You
Dec 17Wockhardt Limited's (NSE:WOCKPHARMA) Shares Climb 29% But Its Business Is Yet to Catch Up
Nov 02What Wockhardt Limited's (NSE:WOCKPHARMA) 27% Share Price Gain Is Not Telling You
Aug 20Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jul 27Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Jun 30Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation
Jun 22Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%
Feb 21There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump
Dec 19There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues
Oct 14Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Feb 18Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being
Jul 26Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
May 18Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Jan 26
What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?
Dec 01Financial Position Analysis
Short Term Liabilities: WOCKPHARMA's short term assets (₹28.1B) exceed its short term liabilities (₹17.4B).
Long Term Liabilities: WOCKPHARMA's short term assets (₹28.1B) exceed its long term liabilities (₹19.2B).
Debt to Equity History and Analysis
Debt Level: WOCKPHARMA's net debt to equity ratio (27.6%) is considered satisfactory.
Reducing Debt: WOCKPHARMA's debt to equity ratio has reduced from 88.7% to 47.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WOCKPHARMA has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: WOCKPHARMA has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 39.5% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/09 08:22 |
| End of Day Share Price | 2025/12/09 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wockhardt Limited is covered by 13 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Aarthisundari Jayakumar | Batlivala & Karani Securities India Pvt. Ltd. |